Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2024-11-08 00:00:00 ET · period of report 2024-11-06 · accession 0001610717-24-000518 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-11-08 | 2024-11-06 | RVMD | Cislini Jeff | GC | S - Sale+OE | $60.00 | -6,000 | 45.6K | -12% | -$360.0K |
| DT | 2024-11-08 | 2024-11-06 | RVMD | Cislini Jeff | GC | M - OptEx | $36.57 | +6,000 | 51.6K | +13% | +$219.4K |
| DT | 2024-11-08 | 2024-11-06 | RVMD | Cislini Jeff | GC | M - OptEx | $0.00 | -6,000 | 30.0K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-06 | S | D | 6,000 | $60.00 | 45,634 | D | — | — | (F2) Includes 40,209 restricted stock units. |
| 2 | Common | Common Stock | 2024-11-06 | M | A | 6,000 | $36.57 | 51,634 | D | — | — | (F2) Includes 40,209 restricted stock units. |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-11-06 | M | D | 6,000 | $0.00 | 30,000 | D | $36.57 · 2024-06-15 to 2030-06-16 | 6,000 Common Stock |